Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy (Q34058221)

30 July 2017

title

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. (English)

1 reference

hypertrophic obstructive cardiomyopathy

30 July 2017

main subject

0 references

author name string

U Sigwart

series ordinal

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 1995

1 reference

30 July 2017

1 reference

30 July 2017

volume

346

1 reference

30 July 2017

issue

8969

1 reference

30 July 2017

page(s)

211-214

1 reference

Functional aortic stenosis; a malformation characterized by resistance to left ventricular outflow without anatomic obstruction

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Hypertrophic cardiomyopathy--continued progress

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Calcium antagonist agents in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Pacing for obstructive hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Current operative treatment of obstructive hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Surgical versus medical therapy of hypertrophic cardiomyopathy: is the perspective changing?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Mitral valve replacement in hypertrophic cardiomyopathy: ten-year follow-up in 54 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Comparison of ventricular septal surgery and mitral valve replacement for hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991267-3

7 January 2021

10.1016/S0140-6736(95)91267-3

Identifiers

DOI

1 reference

30 July 2017

1 reference